AUG 25, 2020 6:36 AM PDT

Doing More with Less: Making the Diagnosis of Heart Damage Easier for Patients

WRITTEN BY: Jasper Cantrell

Cardiovascular health can be a tricky thing to diagnose. Sometimes it can be done with simple heart rate and blood pressure readings, and other times it needs a dozen or more blood tests. What if there was a way to make the process easier?

A team from the University of Tours in France wanted to try their hand at this and use something called limited sampling strategy (LSS) to measure infarct size. An infarct is an area of dead tissue in the heart, caused by cardiovascular disease or event. Standard testing needs to draw blood every four hours over three days, which is discomforting for patients. These samples are used to follow biomarkers, such as creatine kinase, tropinons, and myocardial creatine kinase, to estimate the infarct size. Using the limited sampling strategy, they intended to cut the number of blood samples needed down to three, and still get a reliable result.

The main limiting factor was data analysis. Current methods require a large data pool to make a reliable decision. They hoped Bayesian estimators, a statistical tool used in drug monitoring, to get the same results with fewer data. If it worked, this data analysis method could identify infarct size, with far less discomfort to patients.

They would use patient data already gathered from five previous clinical trials to develop and test their method. In the trials, the blood samples were taken every four hours for three days. To make sure that they chose the best time to take the blood samples and how many blood samples they should take, they analyzed each biomarker’s data at each time-point. Their findings showed that when limited to three samples, the ideal times to draw them would be at 4, 12, and 20 hours. The final results were comparable to current methods.

Overall, the study accomplished what it intended to. The team developed a simple method and cut down the required blood samples by six-fold. The team does note that the amount of data they used was relatively small, and they could not test some other relevant biomarkers, so further validation would be needed.

The study concludes, “We demonstrated that biomarker kinetics can be assessed using a limited number of samples (2 or 3 samples, which means until 7 times less than in current protocols) thanks to Bayesian kinetic modelling.”

Sources: Nature Scientific Reports, MassGeneralHospital

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
AUG 05, 2020
Cannabis Sciences
Cannabis Might Trigger Heart Problems Says AHA
AUG 05, 2020
Cannabis Might Trigger Heart Problems Says AHA
The American Heart Association (AHA) has produced a new statement about medical marijuana and recreational cannabis. The ...
AUG 22, 2020
Cardiology
Can Playing Your Favorite Music Improve Your Physical Performance?
AUG 22, 2020
Can Playing Your Favorite Music Improve Your Physical Performance?
If you go to the gym, you will usually see people with headphones jamming out to their favorite music while exercising. ...
SEP 17, 2020
Cardiology
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
SEP 17, 2020
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
One of the biggest issues with chemotherapy treatments is their inherent toxicities. Most chemotherapy drugs are toxic t ...
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
NOV 19, 2020
Cardiology
Examining a Possible Link Between Atherosclerosis and Inflammation
NOV 19, 2020
Examining a Possible Link Between Atherosclerosis and Inflammation
The immune system’s primary duty is to protect the body from dangerous invaders. Many don’t know that it als ...
DEC 07, 2020
Cell & Molecular Biology
An Autoimmune Link to Heart Disease is ID'ed
DEC 07, 2020
An Autoimmune Link to Heart Disease is ID'ed
CNIC researchers have found that there is an autoimmune link to cardiovascular disease that may improve diagnostic and t ...
Loading Comments...